Contact
Please use this form to send email to PR contact of this press release:
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
TO:
Please use this form to send email to PR contact of this press release:
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Data Selected for Oral Presentation at ASCO 2025
TO: